Wird geladen...
Development and prevalence of castration-resistant prostate cancer subtypes
BACKGROUND: Castration-resistant prostate cancer (CRPC) occurs when prostate cancer (CaP) progresses under therapy-induced castrate conditions. Several mechanisms have been proposed to explain this acquired resistance, many of which are driven by androgen receptor (AR). Recent findings, however, sub...
Gespeichert in:
| Veröffentlicht in: | Neoplasia |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Neoplasia Press
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7522286/ https://ncbi.nlm.nih.gov/pubmed/32980775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2020.09.002 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|